Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
J Microbiol Immunol Infect. 2012 Jun;45(3):228-36. doi: 10.1016/j.jmii.2011.11.007. Epub 2012 May 7.
BACKGROUND/PURPOSE: Proteus mirabilis is a common pathogen responsible for complicated urinary tract infections (UTIs) that sometimes causes bacteremia. Most cases of P. mirabilis bacteremia originate from a UTI; however, the risk factors for bacteremia and mortality rates from P. mirabilis UTI have not been determined.
A retrospective, case-control study was performed between May 2008 and November 2010 to identify the risk factors and markers for P. mirabilis bacteremic UTI. Each subject in the case group (all patients were diagnosed with P. mirabilis bacteremia from a urinary tract source) was matched by age and gender to two subjects in the control group (patients diagnosed with P. mirabilis UTI but with negative blood culture results). Clinical presentation and laboratory data were analyzed to determine the risk factors and markers of P. mirabilis bacteremic UTI.
Sixty-seven bacteremic UTIs and 124 nonbacteremic UTIs were included in this study. Community-acquired infection (p=0.017), hydronephrosis (p=0.017), band neutrophils accounting for >10% of the white blood cell count (p=0.001), hyperthermia or hypothermia (p=0.047), and a serum C-reactive protein concentration >100mg/L (p=0.002) were identified as independent risk factors for P. mirabilis bacteremic UTI. Seventeen patients died in hospital, including 11 in the bacteremic group and 6 in the nonbacteremic group. The bacteremic group had a higher mortality rate (p=0.016). Bacteremic UTI (p=0.049), shock (p=0.014), and a low body mass index (BMI) <18 kg/m(2) (p=0.033) were identified as independent risk factors for mortality.
Because bacteremic P. mirabilis UTIs are associated with higher mortality, clinicians should carefully manage cases that present with the risk factors for bacteremia, including community-acquired infection, hydronephrosis, band neutrophils accounting for >10% of the white blood cell count, hyperthermia or hypothermia, and a high level of C-reactive protein.
背景/目的:奇异变形杆菌是一种常见的病原体,可导致复杂的尿路感染(UTI),有时还会引起菌血症。大多数奇异变形杆菌菌血症病例源自 UTI;然而,奇异变形杆菌 UTI 导致菌血症的风险因素和死亡率尚未确定。
本研究采用回顾性病例对照研究,于 2008 年 5 月至 2010 年 11 月期间确定奇异变形杆菌菌血症性 UTI 的风险因素和标志物。病例组(所有患者均从尿路感染来源诊断为奇异变形杆菌菌血症)中的每位患者均按年龄和性别与对照组中的两位患者相匹配(诊断为奇异变形杆菌 UTI 但血培养结果为阴性的患者)。分析临床表现和实验室数据,以确定奇异变形杆菌菌血症性 UTI 的风险因素和标志物。
本研究纳入了 67 例菌血症性 UTI 和 124 例非菌血症性 UTI。社区获得性感染(p=0.017)、肾盂积水(p=0.017)、白细胞计数中带核细胞占比>10%(p=0.001)、发热或低体温(p=0.047)和血清 C 反应蛋白浓度>100mg/L(p=0.002)被确定为奇异变形杆菌菌血症性 UTI 的独立危险因素。17 名患者在住院期间死亡,其中菌血症组 11 例,非菌血症组 6 例。菌血症组的死亡率较高(p=0.016)。菌血症性 UTI(p=0.049)、休克(p=0.014)和低体重指数(BMI)<18kg/m²(p=0.033)被确定为死亡的独立危险因素。
由于奇异变形杆菌菌血症性 UTI 与较高的死亡率相关,因此临床医生应仔细管理具有菌血症风险因素的病例,包括社区获得性感染、肾盂积水、白细胞计数中带核细胞占比>10%、发热或低体温以及 C 反应蛋白水平升高。